Literature DB >> 8969329

Update and evaluation of Australian guidelines. Government perspective.

A Mitchell1.   

Abstract

Mesh:

Year:  1996        PMID: 8969329

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  5 in total

Review 1.  Quality use of medicines in the community: the Australian experience.

Authors:  A J Smith; P McGettigan
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

2.  Health economics in the Canadian pharmaceutical industry.

Authors:  L Assiff; M R Pollock; P Manzi; B Faienza; D Menon
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 3.  Socioeconomic evaluation in medicine in Europe. Core economic concepts.

Authors:  K Berger; T D Szucs
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

4.  Ontario's formulary committee: how recommendations are made.

Authors:  Anne M PausJenssen; Peter A Singer; Allan S Detsky
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Drug policy down under: Australia's pharmaceutical benefits scheme.

Authors:  Stephen J Duckett
Journal:  Health Care Financ Rev       Date:  2004
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.